What is the difference between Humulin R (regular insulin) and Humulin N (NPH insulin) in terms of usage and dosage for a patient with diabetes requiring insulin therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Humulin R vs Humulin N: Key Differences in Usage and Dosage

Fundamental Pharmacologic Differences

Humulin R (regular insulin) and Humulin N (NPH insulin) serve completely different physiologic roles and cannot be used interchangeably. Humulin R is a short-acting insulin designed for mealtime (prandial) coverage, while Humulin N is an intermediate-acting insulin used for basal coverage 1.

Humulin R (Regular Insulin)

  • Onset: 0.5-1 hour after injection 1
  • Peak action: 2-4 hours 1
  • Duration: 5-8 hours 1
  • Primary use: Controls postprandial glucose excursions when given before meals 1
  • Administration timing: Must be given 30-45 minutes before meals for optimal effect 1, 2

Humulin N (NPH Insulin)

  • Onset: 1-2 hours after injection 1
  • Peak action: 4-6 hours 1
  • Duration: 10-16 hours 1
  • Primary use: Provides intermediate-acting basal insulin coverage to suppress hepatic glucose production between meals and overnight 1
  • Administration timing: Typically given once or twice daily 1

Clinical Usage Patterns

Type 2 Diabetes

For initial insulin therapy in type 2 diabetes, basal insulin (NPH or long-acting analogs) is typically added first, not regular insulin. 1

  • Starting with NPH: Begin at 10 units once daily or 0.1-0.2 units/kg/day, administered at bedtime 1
  • Titration: Increase by 2-4 units every 3 days until fasting glucose reaches 80-130 mg/dL 1
  • When to add Humulin R: Only add prandial regular insulin when basal insulin has been optimized (fasting glucose controlled) but HbA1c remains above target after 3-6 months, or when basal insulin exceeds 0.5 units/kg/day without achieving goals 1

Starting dose of Humulin R when adding prandial coverage: 4 units before the largest meal, or 10% of the current basal dose 1

Type 1 Diabetes

Type 1 diabetes requires BOTH basal and prandial insulin from diagnosis. 1, 2

  • Total daily dose: Typically 0.5 units/kg/day for metabolically stable patients 1, 3
  • Distribution: Approximately 50% as basal insulin (NPH) and 50% as prandial insulin (regular or rapid-acting) divided among meals 1, 3
  • NPH dosing: Given once or twice daily; if twice daily, typically split as 2/3 in morning and 1/3 at bedtime 1
  • Humulin R dosing: Given 30-45 minutes before each meal based on carbohydrate intake 1, 2

Critical Timing Differences

The 30-45 minute pre-meal timing requirement for Humulin R is a major disadvantage compared to rapid-acting analogs, which can be given 0-15 minutes before meals. 1, 2 This makes Humulin R less attractive for prandial coverage in modern practice, though it remains a cost-effective option 1.

Combination Therapy Considerations

When using both Humulin R and Humulin N together:

  • They can be mixed in the same syringe if needed, though this is less common with modern regimens 4
  • When mixed with NPH, inject within 15 minutes before a meal 2
  • The combination provides both basal coverage (NPH) and mealtime coverage (regular insulin) 1, 4

Special Clinical Situations

Glucocorticoid-Induced Hyperglycemia

NPH insulin is the preferred choice for steroid-induced hyperglycemia because its 4-6 hour peak action matches the diurnal hyperglycemia pattern from morning prednisone. 1 Give NPH concomitantly with steroids, as the peak action aligns with steroid-induced glucose elevation 1.

Hospitalized Patients

  • Basal-bolus regimens using scheduled insulin are superior to sliding scale monotherapy 1, 5
  • For non-critically ill patients eating regular meals: 50% of total daily dose as basal (NPH or long-acting) and 50% as bolus (regular or rapid-acting) divided among meals 1, 3
  • Never use sliding scale insulin as monotherapy—this approach is explicitly condemned by all major guidelines 1, 5

Concentrated Regular Insulin (U-500)

Humulin R U-500 is five times more concentrated than standard U-100 and has unique properties: it works as BOTH basal and prandial insulin due to delayed onset and longer duration of action 1, 6. It is indicated for patients requiring more than 200 units of insulin per day 1, 6.

Cost Considerations

NPH insulin is significantly less expensive than long-acting insulin analogs (glargine, detemir, degludec) and may be a more affordable basal option for some patients, though it carries modestly higher risk of nocturnal hypoglycemia. 1 Regular insulin is also less costly than rapid-acting analogs 1.

Common Pitfalls to Avoid

  • Never use Humulin R at bedtime—this significantly increases nocturnal hypoglycemia risk 1, 3
  • Never rely on Humulin R alone for basal coverage—its 5-8 hour duration is insufficient for 24-hour basal needs 1
  • Never give NPH for acute mealtime correction—its delayed onset and prolonged action make it inappropriate for prandial use 1
  • Don't forget the 30-45 minute pre-meal timing for Humulin R—giving it at mealtime results in inadequate postprandial control 1, 2
  • Continue metformin when adding insulin therapy unless contraindicated—this combination reduces insulin requirements and weight gain 1, 2, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

EADSG Guidelines: Insulin Therapy in Diabetes.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 2018

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Insulin management of type 2 diabetes mellitus.

American family physician, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.